LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 84.82 | 17.25 | 9682 | 5924 | 1.6343 | 1.1201 | MN20160310_N02 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 86.79 | 17.25 | 117 | 6008 | 0.0195 | 0.2545 | MN20160310_N02 | E22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 86.79 | 17.25 | 10039 | 6008 | 1.6709 | 1.1254 | MN20160310_N02 | E22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 86.79 | 17.25 | 3 | 6008 | 0.0005 | -0.1871 | MN20160310_N02 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 86.79 | 17.25 | 9949 | 6008 | 1.6559 | 1.1231 | MN20160310_N02 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 88.76 | 17.25 | 103 | 6047 | 0.0170 | 0.2354 | MN20160310_N02 | E22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 88.76 | 17.25 | 10383 | 6047 | 1.7168 | 1.1320 | MN20160310_N02 | E22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 88.76 | 17.25 | 2 | 6047 | 0.0003 | -0.2250 | MN20160310_N02 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 88.76 | 17.25 | 10148 | 6047 | 1.6779 | 1.1263 | MN20160310_N02 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 90.74 | 17.25 | 90 | 6109 | 0.0147 | 0.2154 | MN20160310_N02 | E22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 90.74 | 17.25 | 10733 | 6109 | 1.7568 | 1.1376 | MN20160310_N02 | E22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 90.74 | 17.25 | 2 | 6109 | 0.0003 | -0.2247 | MN20160310_N02 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 90.74 | 17.25 | 10434 | 6109 | 1.7078 | 1.1305 | MN20160310_N02 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 92.71 | 17.25 | 82 | 6184 | 0.0133 | 0.2017 | MN20160310_N02 | E22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 92.71 | 17.25 | 11027 | 6184 | 1.7831 | 1.1411 | MN20160310_N02 | E22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 92.71 | 17.25 | 1 | 6184 | 0.0002 | -0.2851 | MN20160310_N02 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 92.71 | 17.25 | 10699 | 6184 | 1.7301 | 1.1335 | MN20160310_N02 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 94.68 | 17.25 | 85 | 6239 | 0.0136 | 0.2064 | MN20160310_N02 | E22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 94.68 | 17.25 | 11410 | 6239 | 1.8287 | 1.1472 | MN20160310_N02 | E22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 94.68 | 17.25 | 1 | 6239 | 0.0002 | -0.2847 | MN20160310_N02 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 94.68 | 17.25 | 10928 | 6239 | 1.7515 | 1.1363 | MN20160310_N02 | N21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 3.06 | 17.25 | 1 | 143 | 0.0070 | -0.6065 | MN20160310_N02 | K14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 3.06 | 17.25 | 469 | 143 | 3.2748 | 1.9496 | MN20160310_N02 | K14 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 3.06 | 17.25 | 1 | 143 | 0.0070 | -0.6065 | MN20160310_N02 | L04 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 3.06 | 17.25 | 477 | 143 | 3.3307 | 1.9659 | MN20160310_N02 | L04 |